Dr. Salas is an Executive Medical Director, Head of Epidemiology, and Therapeutic Area Lead of Specialty Medicine at the Clinical Safety and Pharmacovigilance Department (CSPV) at Daiichi Sankyo Inc. She has experience in Pharmacoepidemiology, Pharmacovigilance, Pharmacoeconomics, Clinical Epidemiology, and Outcomes Research. Dr. Salas is a medical doctor and epidemiologist with more than 20 years of experience in pharmacovigilance and pharmacoepidemiology. Dr. Salas holds degrees in Medicine, Outcomes Research, Epidemiology, Clinical Epidemiology, and Pharmacoepidemiology. She worked in the Internal Medicine Department at the National Medical Center. She also worked at the Department of Preventive Medicine and School of Public Health (SOPH) at the University of Alabama at Birmingham. At the SOPH, Dr. Salas developed the Pharmacoepidemiology program and represented the Birmingham Center for Education, Research and Therapeutics (CERTs) at the CERTs National Educational Consortium. As a pharmacoepidemiologist, Dr. Salas wanted to get experience in the pharmaceutical industry, and she joined the Patient Safety Departments at AstraZeneca Pharmaceuticals, Pfizer Inc, Merck Research Laboratories, and, lately, Daiichi Sankyo Incorporated, where she is responsible for the development of the Global Pharmacoepidemiology Department, CSPV. Dr. Salas obtained various federal grants, worked with multiple large databases, published more than 100 scientific articles in peer-reviewed journals, and has more than 1000 citations in the scientific literature.